Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gasses such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine, and rarely, to stresses such as vigorous exercise and heat.
Biomarker and diagnostic research for malignant hyperthermia of anesthesia has been reported in the published literature.
1 FDA-approved treatment is available for malignant hyperthermia of anesthesia, including DANTROLENE SODIUM (DANTRIUM, approved 1979).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
212 publications have been identified in PubMed for malignant hyperthermia of anesthesia. Kisho has analyzed 121 by research type. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (15%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 57 |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
RYANODEX DANTROLENE SODIUM
DANTROLENE SODIUM |
Blocks Ryanodine receptor 3 |
2014 |
Available |
DANTRIUM | DANTROLENE SODIUM | — | 1979 | Available |
FDA adverse event reports (FAERS) include all outcomes reported during treatment and do not establish causation. Report counts reflect all approved indications for each drug, not only this disease.
1,154 adverse event reports have been filed with the FDA for DANTROLENE SODIUM (across all indications). Most commonly reported: amnesia, asthenia, and blood creatine phosphokinase increased.
Gene therapy approaches for malignant hyperthermia of anesthesia have been reported in the published literature.
2 trials found
Research summaries | 18 | 15% |
Laboratory research | 17 | 14% |
Disease patterns and progression | 10 | 8% |
Testing and diagnosis research | 6 | 5% |
New treatment approaches | 6 | 5% |
Clinical study results | 4 | 3% |
Other research | 3 | 2% |
Altınoluk T (2026). [PMID: 41843253](https://pubmed.ncbi.nlm.nih.gov/41843253/). *Vet Res Commun*. [Review / Meta-Analysis]
Thachuk C (2026). [PMID: 41036649](https://pubmed.ncbi.nlm.nih.gov/41036649/). *Lifestyle genomics*. [Review / Meta-Analysis]
Kudo A (2026). [PMID: 41962260](https://pubmed.ncbi.nlm.nih.gov/41962260/). *Vet Anaesth Analg*. [Case Report / Case Series]
Maino A (2026). [PMID: 41017341](https://pubmed.ncbi.nlm.nih.gov/41017341/). *European journal of anaesthesiology*. [Case Report / Case Series]
Ye X (2026). [PMID: 41130848](https://pubmed.ncbi.nlm.nih.gov/41130848/). *J Cardiothorac Vasc Anesth*. [Diagnostic / Biomarker]
Parrino CR (2026). [PMID: 41644408](https://pubmed.ncbi.nlm.nih.gov/41644408/). *Transplantation proceedings*. [Gene Therapy / Novel Therapeutics]
Suzuki M (2026). [PMID: 41485933](https://pubmed.ncbi.nlm.nih.gov/41485933/). *Nihon yakurigaku zasshi. Folia pharmacologica Japonica*. [Case Report / Case Series]
Rüffert H (2026). [PMID: 41478797](https://pubmed.ncbi.nlm.nih.gov/41478797/). *British journal of anaesthesia*. [Review / Meta-Analysis]
Sarıkaya Uzan G (2026). [PMID: 41675683](https://pubmed.ncbi.nlm.nih.gov/41675683/). *Molecular syndromology*. [Case Report / Case Series]
Bloom J (2026). [PMID: 41298171](https://pubmed.ncbi.nlm.nih.gov/41298171/). *Journal of cardiothoracic and vascular anesthesia*. [Case Report / Case Series]